Skip to main content
Signal8

GLOBUS MEDICAL INC (GMED)

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices. The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs. Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Devices

Globus Medical, Inc. logo

Globus Medical, Inc.

NYSE:GMEDHealthcare
-0.31%$81.41
AH Close$81.41+0.00%vs close
Mkt Cap$10.93B
Float131.09M
O/S134.26M
Inst Own88.4%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$10.93B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership88.42%

based on 134.26M shares outstanding

SectorHealthcare
IndustryMedical - Devices
ExchangeNYSE
CountryUSUS
IPO DateAug 3, 2012
Shares Outstanding134.26M
Float131.09M
Company Overview

Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices, all designed to treat conditions such as degenerative diseases, deformities, tumors, and trauma. Furthermore, they offer advanced motion preservation technologies, including dynamic stabilization, total disc replacement, and interspinous distraction devices.

The company also provides interventional pain management options for vertebral compression fractures, alongside a selection of regenerative biologic products such as allografts and synthetic alternatives. Beyond spinal care, Globus Medical manufactures solutions for orthopedic trauma, featuring products like fracture plates, compression screws, intramedullary nails, and external fixation systems. They also specialize in hip and knee joint reconstruction, offering modular hip stems, acetabular cups, and various knee arthroplasty implants, including posterior stabilizing and cruciate retaining designs.

Additionally, the company engages in the distribution of human cell, tissue, and other cellular and tissue-based products. Established in 2003, Globus Medical, Inc. maintains its corporate headquarters in Audubon, Pennsylvania.

Leadership

Ann D. Rhoads

Director

Daniel J. Wolterman

Director

Daniel T. Lemaitre

Director

David C. Paul

Co-Founder & Executive Chairman

Employees

6K+

Country

US

Sector

Healthcare

Website

globusmedical.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
27
HOLD
8
SELL
1
TOTAL36
Insider Trading
InsiderTypeShares
TOBIN JAMES R profile photoTOBIN JAMES ROption Exercise15.0K
TOBIN JAMES R profile photoTOBIN JAMES ROption Exercise15.0K
TOBIN JAMES R profile photoTOBIN JAMES ROption Exercise15.0K
TOBIN JAMES R profile photoTOBIN JAMES RSale30.0K
TOBIN JAMES R profile photoTOBIN JAMES ROption Exercise15.0K
ZARRILLI STEPHEN T profile photoZARRILLI STEPHEN TOption Exercise25.0K
Shareholders
88.4%
Institutional
(609)
0.5%
Insiderⓘ
(4)
5.2%
5%+ Owners
(1)
5.9%
Unattributed (incl. retail)ⓘ
Institutional88.4%
Insider0.5%
5%+ Beneficial5.2%
Unattributed (incl. retail)5.9%
Sources: 13F, Form 4, 13D/13GO/S: 134.3M · as of 4 Aug 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$54.15$101.40
$81.41(58th percentile)
Volume
Average Daily Volume1.44M
768.46K today vs 1.44M avg(-47%)

30d Avg

1.44M

60d Avg

1.46M

90d Avg

1.43M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...